Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Insulet (Nasdaq:PODD) today hosted its Investor Day event, led by CEO Ashley McEvoy, laying out the future for the insulin ...

Insulet also expects in 2028 to release the Omnipod Fully Closed Loop for Type 2, which will automate insulin delivery for patients with type 2 diabetes. It said the out-of-the-box product will be the ...

Shares of Insulet Corporation (PODD) slipped ~7% on Thursday as the insulin pump maker announced its long-term financial ...

Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s ...

Diabetes is a chronic health condition affecting blood glucose levels. In some cases, it requires constant management in the form of monitoring blood glucose levels and administering insulin.

Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented ...

The way we move from A to B in cities and beyond is changing. We're not only seeing automakers commit to an electric future, but also investing in autonomous driving technologies. Electronics giant LG ...

Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.

ACTON, Mass., June 26, 2021--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, ...